Sciex Donates to World Cancer Research Fund
Sciex has donated $17,500 to the World Cancer Research Fund (WCRF) to help fund urgently‑needed research investigating the relationships between food, nutrition, and physical activity with cancer prognosis and outcome in cancer survivors.
Sciex (Framingham, Massachusetts, USA) has donated $17,500 to the World Cancer Research Fund (WCRF) to help fund urgentlyâneeded research investigating the relationships between food, nutrition, and physical activity with cancer prognosis and outcome in cancer survivors.
A donation of $11,000 was made as the result of 98% participation in the annual Sciex employee engagement survey, where Sciex committed to donating to this cause based on the number of survey responses collected. An additional $6500 was donated by the Danaher Foundation, the parent company of Sciex.
“Sciex is very proud to support organizations that promote healthcare research and discovery, community engagement, and efforts towards innovative approaches to improve quality of life around the world,” said Inese Lowenstein, President of Sciex
Gerard Cousins, Director of Fundraising for WCRF UK, commented: “WCRF is proud to have been working with Sciex, an organization that shares our aim of empowering people to make healthier lifestyle choices, since 2015. Sciex fundraising has helped to fund much-needed research into cancer prevention, which has been reflected in our latest report, Diet, Nutrition, Physical Activity and Cancer: a Global Perspective, which was launched in May.”
For more information, please visit www.sciex.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
